Form 8-K - Current report:
SEC Accession No. 0001104659-24-109855
Filing Date
2024-10-18
Accepted
2024-10-18 16:15:23
Documents
13
Period of Report
2024-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426509d1_8k.htm   iXBRL 8-K 24416
  Complete submission text file 0001104659-24-109855.txt   199101

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zura-20241015.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20241015_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20241015_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2426509d1_8k_htm.xml XML 3803
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 241380934
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)